- Home
- LRE vs VSTM Comparison
LRE vs VSTM Comparison
Compare LRE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- VSTM
- Stock Information
- Founded
- LRE 2001
- VSTM 2010
- Country
- LRE Japan
- VSTM United States
- Employees
- LRE N/A
- VSTM N/A
- Industry
- LRE
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- LRE
- VSTM Health Care
- Exchange
- LRE Nasdaq
- VSTM Nasdaq
- Market Cap
- LRE 17.6M
- VSTM 425.9M
- IPO Year
- LRE 2023
- VSTM 2012
- Fundamental
- Price
- LRE $1.80
- VSTM $4.34
- Analyst Decision
- LRE
- VSTM Strong Buy
- Analyst Count
- LRE 0
- VSTM 9
- Target Price
- LRE N/A
- VSTM $12.63
- AVG Volume (30 Days)
- LRE 15.3K
- VSTM 2.2M
- Earning Date
- LRE 01-01-0001
- VSTM 08-07-2025
- Dividend Yield
- LRE N/A
- VSTM N/A
- EPS Growth
- LRE N/A
- VSTM N/A
- EPS
- LRE 0.29
- VSTM N/A
- Revenue
- LRE $117,804,154.00
- VSTM $10,000,000.00
- Revenue This Year
- LRE N/A
- VSTM $129.06
- Revenue Next Year
- LRE N/A
- VSTM $306.32
- P/E Ratio
- LRE $6.19
- VSTM N/A
- Revenue Growth
- LRE 8.82
- VSTM N/A
- 52 Week Low
- LRE $1.10
- VSTM $2.10
- 52 Week High
- LRE $2.49
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- LRE 54.60
- VSTM 26.56
- Support Level
- LRE $1.64
- VSTM $4.01
- Resistance Level
- LRE $2.11
- VSTM $6.62
- Average True Range (ATR)
- LRE 0.14
- VSTM 0.29
- MACD
- LRE -0.01
- VSTM -0.11
- Stochastic Oscillator
- LRE 24.49
- VSTM 9.17
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.